Jeffrey B Kopp Selected Research

Apolipoprotein L1

1/2022	Antisense oligonucleotides ameliorate kidney dysfunction in podocyte-specific APOL1 risk variant mice.
1/2022	Impact of APOL1 kidney risk variants on glomerular transcriptomes.
1/2022	APOL1 Risk Variants Associated with Serum Albumin in a Population-Based Cohort Study.
10/2021	The key role of NLRP3 and STING in APOL1-associated podocytopathy.
1/2021	APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis.
1/2019	APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice.
11/2018	APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.
1/2018	Fetal-Not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry.
1/2018	ApoL1 renal risk variants induce aberrant THP-1 monocyte differentiation and increase eicosanoid production via enhanced expression of cyclooxygenase-2.
3/2016	A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey B Kopp Research Topics

Disease

35	Kidney Diseases (Kidney Disease) 01/2022 - 09/2002
31	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 02/2022 - 02/2006
27	Proteinuria 01/2022 - 06/2005
22	Fibrosis (Cirrhosis) 01/2022 - 03/2002
16	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 08/2003
15	Chronic Renal Insufficiency 04/2022 - 09/2007
15	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 02/2010
13	Albuminuria 10/2021 - 06/2005
12	Hypertension (High Blood Pressure) 01/2022 - 04/2009
11	Inflammation (Inflammations) 01/2022 - 01/2002
11	Infections 01/2021 - 02/2003
9	AIDS-Associated Nephropathy (HIV-Associated Nephropathy) 10/2019 - 08/2003
8	Wilms Tumor (Wilm's Tumor) 10/2020 - 02/2007
7	Glomerulonephritis 01/2021 - 04/2002
6	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 09/2004
6	HIV Infections (HIV Infection) 01/2019 - 08/2003
5	Lupus Nephritis 01/2022 - 01/2010
5	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2019 - 02/2006
4	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2022 - 03/2010
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2018
4	Obesity 01/2021 - 12/2013
4	Insulin Resistance 12/2013 - 02/2008
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 06/2009
3	Neoplasms (Cancer) 01/2022 - 11/2004
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 04/2002
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 04/2002
3	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2021 - 04/2002
3	Disease Progression 10/2019 - 03/2002
3	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2018 - 04/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2018
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2005
2	Nephritis 12/2021 - 08/2010
2	Sickle Cell Trait 01/2018 - 07/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 11/2009
2	Stroke (Strokes) 01/2018 - 07/2017
2	Thrombotic Microangiopathies 03/2015 - 03/2008
2	Hyperglycemia 12/2014 - 11/2010
2	Lipodystrophy 09/2013 - 02/2008
2	Cicatrix (Scar) 02/2011 - 01/2003

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2003
19	Apolipoprotein L1IBA 01/2022 - 09/2010
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2008
9	Messenger RNA (mRNA)IBA 01/2021 - 06/2009
8	CreatinineIBA 01/2022 - 01/2011
7	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2022 - 04/2004
7	CytokinesIBA 12/2019 - 01/2002
6	AlbuminsIBA 01/2022 - 06/2005
5	RNA (Ribonucleic Acid)IBA 02/2022 - 10/2017
5	LipidsIBA 01/2022 - 12/2014
5	NPHS2 proteinIBA 10/2020 - 02/2006
5	AutoantibodiesIBA 12/2019 - 04/2002
5	nephrinIBA 12/2014 - 02/2007
5	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2013 - 01/2009
4	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 04/2004
4	InterferonsIBA 01/2022 - 02/2015
4	MicroRNAs (MicroRNA)IBA 01/2022 - 04/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 03/2008
4	CholesterolIBA 01/2021 - 07/2014
4	EnzymesIBA 01/2019 - 09/2004
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 11/2010
4	Pharmaceutical PreparationsIBA 01/2016 - 09/2004
3	InflammasomesIBA 01/2022 - 01/2018
3	Protein Kinases (Protein Kinase)IBA 01/2022 - 01/2013
3	Erythropoietin FDA Link 01/2021 - 07/2007
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021 - 12/2011
3	SteroidsIBA 11/2018 - 11/2007
3	Streptozocin (Streptozotocin)FDA Link 01/2018 - 11/2010
3	vpr Gene ProductsIBA 10/2017 - 02/2008
3	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2015 - 03/2010
3	podocalyxinIBA 04/2012 - 03/2010
3	pirfenidoneIBA 06/2011 - 09/2007
2	Circular RNAIBA 01/2022 - 10/2020
2	ApolipoproteinsIBA 01/2021 - 10/2016
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 02/2007
2	InterleukinsIBA 01/2021 - 12/2011
2	CollagenIBA 01/2021 - 10/2020
2	Fibronectins (Fibronectin)IBA 01/2021 - 04/2004
2	ChemokinesIBA 01/2021 - 10/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 03/2010
2	Serum AlbuminIBA 08/2020 - 02/2006
2	Monoclonal AntibodiesIBA 12/2019 - 03/2008
2	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 11/2004
2	AngiotensinsIBA 01/2019 - 02/2007
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 06/2015
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2018 - 12/2011
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2018 - 08/2017
2	6alpha-ethyl-23(S)-methylcholic acidIBA 01/2018 - 01/2016
2	Antihypertensive Agents (Antihypertensives)IBA 10/2017 - 01/2013
2	Tenofovir (Viread)FDA Link 01/2016 - 05/2013
2	Antigen-Antibody Complex (Immune Complex)IBA 03/2015 - 11/2008
2	AntibodiesIBA 03/2014 - 03/2010
2	Transforming Growth Factor beta (TGF-beta)IBA 09/2011 - 08/2007
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2011 - 01/2010
2	Angiotensin IIIBA 12/2010 - 10/2007
2	Hydralazine (Apresoline)FDA LinkGeneric 12/2010 - 10/2007

Therapy/Procedure

26	Therapeutics 01/2022 - 04/2002
7	Kidney Transplantation 10/2019 - 01/2003
4	Nephrectomy 01/2022 - 01/2005
2	Precision Medicine 01/2018 - 01/2018
2	Highly Active Antiretroviral Therapy (HAART) 05/2013 - 08/2003